C. Mormont

Effects of Angiotensin-Converting Enzyme Inhibition in Low-Risk Patients Early After Coronary Artery Bypass Surgery

Jean L. Rouleau, Wayne Warnica, Richard Baillot et al. · Circulation · 2007 · 159 citations

Medicine, Cardiology, Surgery +13

A phase II trial of dacomitinib, an oral pan-human EGF receptor (HER) inhibitor, as first-line treatment in recurrent and/or metastatic squamous-cell carcinoma of the head and neck

A.R. Abdul Razak, Denis Soulières, Scott A. Laurie et al. · Annals of Oncology · 2012 · 103 citations

Medicine, Oncology, Pharmacology +16

The Difference Between Activity When in Bed and Out of Bed. I. Healthy Subjects and Selected Patients

David Minors, Torbjörn Åkerstedt, Greg Atkinson et al. · Chronobiology International · 1996 · 69 citations

Education, Behavioral Sciences, Health Assessment +11

Characterization of somatostatin receptors and growth inhibition by the somatostatin analogue BIM23014 in small cell lung carcinoma xenograft: SCLC-6

Grégoire Prévost, Yann Bourgeois, C. Mormont et al. · Life Sciences · 1994 · 21 citations

Medicine, Oncology, Pharmacology +17

The synthetic tetrapeptide AcSDKP protects cells that reconstitute long-term bone marrow stromal cultures from the effects of mafosfamide (Asta Z 7654).

MC Genevay, C. Mormont, F Thomas et al. · PubMed · 1996 · 16 citations

Life Sciences, Cell Biology, Pharmacology +12